glp 1 analogue examples Schematic representation of different GLP-1 analogues previously PDB-101: Molecule of the Month:

Plasma not only supports circulation and tissue nourishment but also contributes to immune defence and blood clotting

Hberle J (2013b) Clinical and biochemical aspects of primary and secondary hyperammonemic disorders

GHK-Cu peptide therapy has not been evaluated by the FDA to diagnose, treat, cure, or prevent any disease

Lancet Diabetes Endocrinol 2020;8:447-55

Banks and Kastin reported that radiolabeled DSIP administered peripherally produced detectable DSIP-like immunoreactivity in brain tissue at levels above what non-specific leakage would predict, and that the modified analogue [D-Ala3]-DSIP entered brain at substantially higher levels than the parent compound after intracarotid administration (Banks & Kastin, 1981)